Financing Entrepreneurial Excellence

HistoSonics

Cleantech |
Life Sciences |
Technology |
Advanced Materials |
ICE |
In Alphabetical Order

HistoSonics

Early Stage Partners participated in the Series A early stage venture capital investment in HistoSonics, an Ann Arbor-based company that is commercializing histotripsy as a non-invasive method for ablating tissue. Histotripsy is the harnessing of micro-bubbles created by cavitation in fluid to destroy diseased tissue.

Recent Histosonics News

Former FDA Commissioner von Eschenbach Joins Histosonics Board

MedCityNews

University of Michigan News Service.

Find Out More About ESP

Mike Bunker (rear right) manages Early Stage Partners' investment in HistoSonics with significant involvement by Michigan-based Andy McColm (front center) who was involved with the company in his previous work at the University of Michigan Office of Technology Transfer